Field of Speciality: Urology
Date of Birth: 1980
School of Medicine: Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English
Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.
Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
mesenchymal Cellular
Male-Shot
After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments
His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement Penile Implants , Penile Enhancement , SafeFill and MaleShot into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.
(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)
Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.
OTHER AREAS OF FOCUS
Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male in, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, preservation, Minimally invasive surgery, Hypospadias
Membership of Scientific Organizations
Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Applications
• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en
Read moreField of Speciality: Urology
Date of Birth: 1980
School of Medicine: Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English
Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.
Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
mesenchymal Cellular
Male-Shot
After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments
His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement Penile Implants , Penile Enhancement , SafeFill and MaleShot into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.
(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)
Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.
OTHER AREAS OF FOCUS
Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male in, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, preservation, Minimally invasive surgery, Hypospadias
Membership of Scientific Organizations
Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Applications
• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en
She completed her training at the Charité in Berlin and has been a specialist in radiotherapy for 20 years. She worked as a senior physician in all departments of the Charité in Berlin, and from 2007 to 2015 she was a senior physician and deputy director of the Charité clinic in Berlin. In 2015, she was appointed head of the department of radiotherapy at the University Hospital of Cologne and very successfully headed the clinic there until 2022. Since the end of 2022, she has been heading the private radiotherapy clinic "RadioOnkologie Vosspalais". Clinical areas include radioimmunotherapy, high-precision therapy, multimodal therapy of gynecological tumors and prostate carcinoma.
Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Several randomized clinical trials have been conducted under her leadership.
Professor Dr. Marnitz is an honorary member of the Russian Society of Gynecological Oncology, a member of the professional societies DEGRO, ESTRO, ASTRO. In 2024, Professor Dr. Marnitz will be the president of the congress of the annual conference of the German Society of Radiation Oncology.
Read moreShe completed her training at the Charité in Berlin and has been a specialist in radiotherapy for 20 years. She worked as a senior physician in all departments of the Charité in Berlin, and from 2007 to 2015 she was a senior physician and deputy director of the Charité clinic in Berlin. In 2015, she was appointed head of the department of radiotherapy at the University Hospital of Cologne and very successfully headed the clinic there until 2022. Since the end of 2022, she has been heading the private radiotherapy clinic "RadioOnkologie Vosspalais". Clinical areas include radioimmunotherapy, high-precision therapy, multimodal therapy of gynecological tumors and prostate carcinoma.
Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Several randomized clinical trials have been conducted under her leadership.
Professor Dr. Marnitz is an honorary member of the Russian Society of Gynecological Oncology, a member of the professional societies DEGRO, ESTRO, ASTRO. In 2024, Professor Dr. Marnitz will be the president of the congress of the annual conference of the German Society of Radiation Oncology.
Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach
He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.
Read moreProf. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach
He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.
She received her medical education in Russia. After completing her residency in Berlin, Dr. Steingraeber worked as a specialist and senior physician at the Charité, the Neukölln Hospital in Berlin and in the practice of radiooncology. Dr. Steingraeber speaks fluent Russian. Her clinical specialization includes bronchial carcinoma and breast carcinoma.
Membership/Committee Service:
DEGRO, ARO, DKG, AGSMO
Member of interdisciplinary committees for the development of guidelines:
Esophageal carcinoma
Anal carcinoma
Oropharyngeal/hypopharyngeal carcinoma
Supportive therapy in oncology
Read moreShe received her medical education in Russia. After completing her residency in Berlin, Dr. Steingraeber worked as a specialist and senior physician at the Charité, the Neukölln Hospital in Berlin and in the practice of radiooncology. Dr. Steingraeber speaks fluent Russian. Her clinical specialization includes bronchial carcinoma and breast carcinoma.
Membership/Committee Service:
DEGRO, ARO, DKG, AGSMO
Member of interdisciplinary committees for the development of guidelines:
Esophageal carcinoma
Anal carcinoma
Oropharyngeal/hypopharyngeal carcinoma
Supportive therapy in oncology
orchiopexy in cryptorchidism: a single centre experience with long-term follow-up. PEDIATRIC SURGERY INTERNATIONAL, 18 : 140-141, 2002
Uygur MC, Tan MO, Ünal D, Erol D: The outcome of one-stage repair of proximal hypospadias with wide ventral preputial island flap. PEDIATRIC SURGERY INTERNATIONAL, 18: 139-140, 2002
Dr. Uygur is an international urologist with a Medical Graduate and M.D. Degree from Hacettepe University Medical School, a research fellowship from the Transplantation Laboratory of Helsinki University, and residency in Urology from Hacettepe University Medical School. He has over 300 international and national publications and presentations, with 781 scientific citations to 41 articles. He is a full member of the European Association of Urology, a corresponding member of the American Urological Association, a member of the Society of Urologic Oncology, and a board member of the Turkish Society of Urologic Oncology. He has completed robotic urologic surgery courses at Vanderbilt University Hospital, the Cleveland Clinic, and the USC Norris Comprehensive Cancer Center. He is the Professor of Urology and Chair at the Near East University Medical School, the Chief of Urology at the Anadolu Medical Center in Affiliation with Johns Hopkins Medicine, and the Director of Urooncology and Urologic Robotic Surgery Programmes at the Anadolu Medical Center. He is also a scientific secretary of biannual Ankara Urooncology Courses, and has organized many national or regional Urology and Urooncology meetings.
Read moreorchiopexy in cryptorchidism: a single centre experience with long-term follow-up. PEDIATRIC SURGERY INTERNATIONAL, 18 : 140-141, 2002
Uygur MC, Tan MO, Ünal D, Erol D: The outcome of one-stage repair of proximal hypospadias with wide ventral preputial island flap. PEDIATRIC SURGERY INTERNATIONAL, 18: 139-140, 2002
Dr. Uygur is an international urologist with a Medical Graduate and M.D. Degree from Hacettepe University Medical School, a research fellowship from the Transplantation Laboratory of Helsinki University, and residency in Urology from Hacettepe University Medical School. He has over 300 international and national publications and presentations, with 781 scientific citations to 41 articles. He is a full member of the European Association of Urology, a corresponding member of the American Urological Association, a member of the Society of Urologic Oncology, and a board member of the Turkish Society of Urologic Oncology. He has completed robotic urologic surgery courses at Vanderbilt University Hospital, the Cleveland Clinic, and the USC Norris Comprehensive Cancer Center. He is the Professor of Urology and Chair at the Near East University Medical School, the Chief of Urology at the Anadolu Medical Center in Affiliation with Johns Hopkins Medicine, and the Director of Urooncology and Urologic Robotic Surgery Programmes at the Anadolu Medical Center. He is also a scientific secretary of biannual Ankara Urooncology Courses, and has organized many national or regional Urology and Urooncology meetings.
| Doctor's visit | price on request |
| CyberKnife | $7500 |
Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.
Read moreDr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.
| Doctor's visit | price on request |
| Laparoscopic nephrectomy | $5200 - $8500 |
| Nephrectomy with Da Vinci Robot | $5500 - $7000 |
| Nephrectomy | $5500 - $6500 |
| Doctor's visit | price on request |
| Gamma Knife | $4000 - $4500 |
| Doctor's visit | price on request |
| Gamma Knife | $4000 - $4500 |
2000
Medical School Graduate – Istanbul University, Faculty of Medicine
2005
Radiology Department, Istanbul University, Istanbul Medical Faculty
2022 – Present
Neolife Medical Center
2015 – 2021
Sonomed Imaging Center
2015
Bezmialem Vakıf University
2011 – 2015
Echomar Imaging Center
2010 – 2011
Istanbul Bilim University
2008 – 2009
Derince Military Hospital
2007 – 2008
German Hospital-Taksim
2005 – 2007
Echomar Imaging Center
MRI findings in parosteal osteosarcoma: correlation with histopathology.
Dönmez FY, Tüzün U, Başaran C, Tunaci M, Bilgiç B, Acunaş G. Diagn Interv Radiol.
The diagnostic efficiency of multislice CT virtual bronchoscopy in detecting endobronchial tumors.
Bakir B, Tüzün Ü, Terzibaşioğlu E, Dursun M, Güven K, Salmaslioğlu A, Tunaci A. Tuberk Toraks.
Diffusion MR findings in cyclosporin-A induced encephalopathy.
Aydin K, Donmez F, Tuzun U, Minareci O, Atamer T. Neuroradiology. 2004
Diffusion tensor imaging findings of the brain in subjects with tonsillar ectopia.
Kurtcan S, Alkan A, Yetis H, Tuzun U, Aralasmak A, Toprak H, Ozdemir H. Acta Neurol Belg. 2018 Mar;
Diffusion Tensor Imaging Parameters in Children with Acute Hyperammonemic Encephalopathy Due to Urea Cycle Enzyme Defects and Organic Acidemia.
Kurtcan S, Alkan A, Guler S, Yesil G, Toprak H, Tuzun U, Yetis H, Aralasmak A, Ozdemir H, Iscan A. Current Medical Imaging Reviews. Volume 13, 2017 DOI: 10.2174/
The Contribution of DTI in Determining the Relationship of Epilepsy and Brain Lesions in Children with Tuberous Sclerosis.
Kurtcan S, Alkan A, Guler S, Yesil G, Toprak H, Tuzun U, Yetis H, Aralasmak A, Ozdemir H, Iscan A. Current Medical Imaging Reviews. Volume 13, 2017 DOI: 10.2174/
Brain cranial nerve diffusion changes in Wernicke encephalopathy secondary to necrotizing pancreatitis.
Kurtcan S, Alkan A, Aydin S, Tuzun U, Toprak H. Arch Med Sci Civil Dis 2016;1:e45–e50
Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies.
Ediz S.S, Kurtcan S, Alkan A, Aydin S, Tuzun U, Toprak H, Aralasmak A. Current Medical Imaging Reviews. Volume 13, 2017
Does the Application of Fibrin in Anterior Cruciate Ligament Reconstruction Enhance Graft Healing and Maturation? A Comparative MRI Study of 44 Cases.
Beyzadeoglu T, Pehlivanoglu T, Yildirim K, Buldu H, Tandogan R, Tuzun U. Orthop J Sports Med. 2020 Feb 20;8(2):
Deep learning for assessing image quality in bi-parametric prostate MRI: A feasibility study.
Alis D, Kartal MS, Seker ME, Guroz B, Basar Y, Arslan A, Sirolu S, Kurtcan S, Denizoglu N, Tuzun U, Yildirim D, Oksuz I, Karaarslan E. Eur J Radiol. 2023 Aug;165:110924. doi: 10.1016/j.ejrad.2023.110924. Epub 2023 Jun 11.
Read more
2000
Medical School Graduate – Istanbul University, Faculty of Medicine
2005
Radiology Department, Istanbul University, Istanbul Medical Faculty
2022 – Present
Neolife Medical Center
2015 – 2021
Sonomed Imaging Center
2015
Bezmialem Vakıf University
2011 – 2015
Echomar Imaging Center
2010 – 2011
Istanbul Bilim University
2008 – 2009
Derince Military Hospital
2007 – 2008
German Hospital-Taksim
2005 – 2007
Echomar Imaging Center
MRI findings in parosteal osteosarcoma: correlation with histopathology.
Dönmez FY, Tüzün U, Başaran C, Tunaci M, Bilgiç B, Acunaş G. Diagn Interv Radiol.
The diagnostic efficiency of multislice CT virtual bronchoscopy in detecting endobronchial tumors.
Bakir B, Tüzün Ü, Terzibaşioğlu E, Dursun M, Güven K, Salmaslioğlu A, Tunaci A. Tuberk Toraks.
Diffusion MR findings in cyclosporin-A induced encephalopathy.
Aydin K, Donmez F, Tuzun U, Minareci O, Atamer T. Neuroradiology. 2004
Diffusion tensor imaging findings of the brain in subjects with tonsillar ectopia.
Kurtcan S, Alkan A, Yetis H, Tuzun U, Aralasmak A, Toprak H, Ozdemir H. Acta Neurol Belg. 2018 Mar;
Diffusion Tensor Imaging Parameters in Children with Acute Hyperammonemic Encephalopathy Due to Urea Cycle Enzyme Defects and Organic Acidemia.
Kurtcan S, Alkan A, Guler S, Yesil G, Toprak H, Tuzun U, Yetis H, Aralasmak A, Ozdemir H, Iscan A. Current Medical Imaging Reviews. Volume 13, 2017 DOI: 10.2174/
The Contribution of DTI in Determining the Relationship of Epilepsy and Brain Lesions in Children with Tuberous Sclerosis.
Kurtcan S, Alkan A, Guler S, Yesil G, Toprak H, Tuzun U, Yetis H, Aralasmak A, Ozdemir H, Iscan A. Current Medical Imaging Reviews. Volume 13, 2017 DOI: 10.2174/
Brain cranial nerve diffusion changes in Wernicke encephalopathy secondary to necrotizing pancreatitis.
Kurtcan S, Alkan A, Aydin S, Tuzun U, Toprak H. Arch Med Sci Civil Dis 2016;1:e45–e50
Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies.
Ediz S.S, Kurtcan S, Alkan A, Aydin S, Tuzun U, Toprak H, Aralasmak A. Current Medical Imaging Reviews. Volume 13, 2017
Does the Application of Fibrin in Anterior Cruciate Ligament Reconstruction Enhance Graft Healing and Maturation? A Comparative MRI Study of 44 Cases.
Beyzadeoglu T, Pehlivanoglu T, Yildirim K, Buldu H, Tandogan R, Tuzun U. Orthop J Sports Med. 2020 Feb 20;8(2):
Deep learning for assessing image quality in bi-parametric prostate MRI: A feasibility study.
Alis D, Kartal MS, Seker ME, Guroz B, Basar Y, Arslan A, Sirolu S, Kurtcan S, Denizoglu N, Tuzun U, Yildirim D, Oksuz I, Karaarslan E. Eur J Radiol. 2023 Aug;165:110924. doi: 10.1016/j.ejrad.2023.110924. Epub 2023 Jun 11.
Areas of Interest
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Liver Cancer
Cervical Cancer
Kidney Cancer
Pancreatic Cancer
Esophageal Cancer
Education
2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology
2009 – 2013
Ufuk University Faculty of Medicine, Department of Internal Medicine
1999 – 2006
Eskişehir Osmangazi University Faculty of Medicine
Work Experience
2024
Neolife Medical Center
2024
Kolan Beylikdüzü Hospital
2023 – 2024
Memorial Bahçelievler Hospital
2020 – 2023
Acıbadem Maslak Hospital
2019 – 2020
İstanbul Aydın University VM Medicalpark Florya Hospital
2017 – 2019
Ministry of Health, Van Education and Research Hospital
2014 – 2017
Hacettepe University Oncology Institute, Medical Oncology Department
2013 – 2014
Kars State Hospital
2009 – 2013
Ufuk University, Dr. Rıdvan Ege Hospital, Department of Internal Medicine
2007 – 2009
Hacettepe University Faculty of Medicine, Department of Physiology
Professional Training
Participation in Turkish Medical Oncology Congresses, National Cancer Congresses, National Immunotherapy and Oncology Congresses
Courses of the Turkish Society of Medical Oncology
Memberships
Turkish Society of Medical Oncology
Istanbul Medical Chamber
Scientific Publications
6 scientific publications in national and international journals
21 abstracts presented at national congresses
3 abstracts presented at international congresses
1 book chapter translation: Atlas of Internal Medicine, 3rd Edition, Chapter 12 – Hepatology, Turkish Translation
3 book chapters:
Areas of Interest
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Liver Cancer
Cervical Cancer
Kidney Cancer
Pancreatic Cancer
Esophageal Cancer
Education
2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology
2009 – 2013
Ufuk University Faculty of Medicine, Department of Internal Medicine
1999 – 2006
Eskişehir Osmangazi University Faculty of Medicine
Work Experience
2024
Neolife Medical Center
2024
Kolan Beylikdüzü Hospital
2023 – 2024
Memorial Bahçelievler Hospital
2020 – 2023
Acıbadem Maslak Hospital
2019 – 2020
İstanbul Aydın University VM Medicalpark Florya Hospital
2017 – 2019
Ministry of Health, Van Education and Research Hospital
2014 – 2017
Hacettepe University Oncology Institute, Medical Oncology Department
2013 – 2014
Kars State Hospital
2009 – 2013
Ufuk University, Dr. Rıdvan Ege Hospital, Department of Internal Medicine
2007 – 2009
Hacettepe University Faculty of Medicine, Department of Physiology
Professional Training
Participation in Turkish Medical Oncology Congresses, National Cancer Congresses, National Immunotherapy and Oncology Congresses
Courses of the Turkish Society of Medical Oncology
Memberships
Turkish Society of Medical Oncology
Istanbul Medical Chamber
Scientific Publications
6 scientific publications in national and international journals
21 abstracts presented at national congresses
3 abstracts presented at international congresses
1 book chapter translation: Atlas of Internal Medicine, 3rd Edition, Chapter 12 – Hepatology, Turkish Translation
3 book chapters:
Prof. Dr. med. Ulrich Graven
Head of the Clinic of Hematology, Oncology and Gastroenterology
Head of a certified oncology center
Head of Clinical Research Department
Specialization:
Hematology, including transplantation
Abdominal oncology, especially colorectal and pancreatic cancer therapy
Metastasis therapy, including the use of off-label drugs
Membership in professional societies:
Professional Union of German Therapists
German Society for Internal Medicine
German Cancer Society
Abdominal Oncology Working Group
German Society of Hematology and Oncology
German Working Group on and Hematopoietic Cell Transplantation
German Society for Digestive and Metabolic Diseases
European Society for Medical Oncology
American Society of Clinical Oncology
American Association for Cancer Research
Activities in professional communities:
German Cancer Society:
Since 2013, speaker of the commission for certification of oncology centers
Since November 2007, member of the board
Since September 2022, Speaker of the Section of National Societies on Cancer Control
Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.
Chairman of the Oncology Society of North Rhine-Westphalia.
Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.
Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.
Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.
Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.
Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.
Member of the committee for the development of clinical guidelines for colorectal cancer.
Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.
Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.
Read moreProf. Dr. med. Ulrich Graven
Head of the Clinic of Hematology, Oncology and Gastroenterology
Head of a certified oncology center
Head of Clinical Research Department
Specialization:
Hematology, including transplantation
Abdominal oncology, especially colorectal and pancreatic cancer therapy
Metastasis therapy, including the use of off-label drugs
Membership in professional societies:
Professional Union of German Therapists
German Society for Internal Medicine
German Cancer Society
Abdominal Oncology Working Group
German Society of Hematology and Oncology
German Working Group on and Hematopoietic Cell Transplantation
German Society for Digestive and Metabolic Diseases
European Society for Medical Oncology
American Society of Clinical Oncology
American Association for Cancer Research
Activities in professional communities:
German Cancer Society:
Since 2013, speaker of the commission for certification of oncology centers
Since November 2007, member of the board
Since September 2022, Speaker of the Section of National Societies on Cancer Control
Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.
Chairman of the Oncology Society of North Rhine-Westphalia.
Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.
Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.
Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.
Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.
Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.
Member of the committee for the development of clinical guidelines for colorectal cancer.
Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.
Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.
Prof. Kıvanç Derya Peker completed his medical education and general surgery specialization at Istanbul University Istanbul Faculty of Medicine (Çapa). After his major specialization, he got his Gastroenterology Surgery Specialization from the Gastroenterology Surgery Clinic of Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital by entering the top 3 in the minor examination.
During his sub-branch assistantship, he received a scholarship from the Turkish Surgery Association and worked at Mayo Clinic (Rochester, USA) Hepatopancreatobiliary Surgery Clinic and Obesity-Metabolic Surgery Clinic. After returning to Turkey, He was one of the founders of the Hepatopancreatobiliary Surgery unit at Bakırköy Dr. Sadi Konuk Training and Research Hospital. Peker provided Hepatopancreatobiliary Surgery training to general surgery residents and gastroenterology surgery residents in this hospital, which is accepted as a training unit by the Turkish HPB Association.
On the other hand; In order to learn , cancer biology, cellular properties of obesity and aging, he did his doctorate and thesis on aging at Istanbul University, Istanbul Faculty of Medicine (Çapa), Department of Medical Biology. Then, he moved to Başakşehir Çam and Sakura City Hospital to establish the Gastroenterology Surgery Clinic.
Especially in his career; He is interested in Pancreatic Diseases and Surgery, Gallbladder and Bile Duct Diseases Surgery, Liver Cancer Surgery, Stomach Cancer Surgery and Obesity-Metabolic Surgery. Peker has carried out many successful operations. He has performed over 400 pancreatic and gastric cancer surgeries, over 200 liver surgeries, many surgeries related to gallbladder and biliary tract diseases, obesity – metabolic surgery and endoscopic treatments, and kidney transplants so far. He is also interested in aging and treatments.
Prof. Kıvanç Derya Peker completed his medical education and general surgery specialization at Istanbul University Istanbul Faculty of Medicine (Çapa). After his major specialization, he got his Gastroenterology Surgery Specialization from the Gastroenterology Surgery Clinic of Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital by entering the top 3 in the minor examination.
During his sub-branch assistantship, he received a scholarship from the Turkish Surgery Association and worked at Mayo Clinic (Rochester, USA) Hepatopancreatobiliary Surgery Clinic and Obesity-Metabolic Surgery Clinic. After returning to Turkey, He was one of the founders of the Hepatopancreatobiliary Surgery unit at Bakırköy Dr. Sadi Konuk Training and Research Hospital. Peker provided Hepatopancreatobiliary Surgery training to general surgery residents and gastroenterology surgery residents in this hospital, which is accepted as a training unit by the Turkish HPB Association.
On the other hand; In order to learn , cancer biology, cellular properties of obesity and aging, he did his doctorate and thesis on aging at Istanbul University, Istanbul Faculty of Medicine (Çapa), Department of Medical Biology. Then, he moved to Başakşehir Çam and Sakura City Hospital to establish the Gastroenterology Surgery Clinic.
Especially in his career; He is interested in Pancreatic Diseases and Surgery, Gallbladder and Bile Duct Diseases Surgery, Liver Cancer Surgery, Stomach Cancer Surgery and Obesity-Metabolic Surgery. Peker has carried out many successful operations. He has performed over 400 pancreatic and gastric cancer surgeries, over 200 liver surgeries, many surgeries related to gallbladder and biliary tract diseases, obesity – metabolic surgery and endoscopic treatments, and kidney transplants so far. He is also interested in aging and treatments.
Assoc. Dr. Görkem TÜRKKAN started his medical education at Gülhane Military Medical Academy in 2003 and completed it in 2009 at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine. He completed his residency in the Department of Radiation Oncology at Trakya University Faculty of Medicine and became a radiation oncology specialist in 2016.
After completing his compulsory service, he served as a Doctor Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology from May 2019 to February 2021. During this period, between March and June 2020, he worked as a clinical researcher in the Department of Radiation Oncology at Maastricht University Medical Center–MAASTRO Clinic (Netherlands) on studies related to stereotactic radiotherapy, thoracic radiation therapy-associated lung toxicity, and proton therapy. Between March 2021 and April 2023, he worked at the Radiation Oncology Department of Istinye University Faculty of Medicine and Liv Hospital Ulus Radiation Oncology Clinic, where he received the title of Associate Professor in February 2023. He has been providing services to his patients at Hisar Hospital Intercontinental since May 2023.
Throughout his professional life, he has performed both traditional and advanced radiotherapy practices. Particularly, he is one of the experienced physicians in Turkey in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which are gaining popularity and usage recently. So far, he has successfully completed over 2500 radiotherapy sessions using the MR-Linac device.
Since 2013, he has been a member of the Turkish Radiation Oncology Society (TROD) and since 2015 a member of the European Society for Radiotherapy and Oncology (ESTRO). He has 27 published articles in national and international journals, 31 oral-poster presentations at national and international congresses, and 5 book chapters published by national and international publishers. He has taught undergraduate courses in Period I and Period V at Muğla Sıtkı Koçman University Faculty of Medicine, master’s courses within the ENT Department Specialist training, and Radiation Therapy associate degree courses at Istinye University Health Services Vocational School. He is currently involved in 2 ongoing TÜBİTAK Projects. He is married and has one son.
Assoc. Dr. Görkem TÜRKKAN started his medical education at Gülhane Military Medical Academy in 2003 and completed it in 2009 at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine. He completed his residency in the Department of Radiation Oncology at Trakya University Faculty of Medicine and became a radiation oncology specialist in 2016.
After completing his compulsory service, he served as a Doctor Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology from May 2019 to February 2021. During this period, between March and June 2020, he worked as a clinical researcher in the Department of Radiation Oncology at Maastricht University Medical Center–MAASTRO Clinic (Netherlands) on studies related to stereotactic radiotherapy, thoracic radiation therapy-associated lung toxicity, and proton therapy. Between March 2021 and April 2023, he worked at the Radiation Oncology Department of Istinye University Faculty of Medicine and Liv Hospital Ulus Radiation Oncology Clinic, where he received the title of Associate Professor in February 2023. He has been providing services to his patients at Hisar Hospital Intercontinental since May 2023.
Throughout his professional life, he has performed both traditional and advanced radiotherapy practices. Particularly, he is one of the experienced physicians in Turkey in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which are gaining popularity and usage recently. So far, he has successfully completed over 2500 radiotherapy sessions using the MR-Linac device.
Since 2013, he has been a member of the Turkish Radiation Oncology Society (TROD) and since 2015 a member of the European Society for Radiotherapy and Oncology (ESTRO). He has 27 published articles in national and international journals, 31 oral-poster presentations at national and international congresses, and 5 book chapters published by national and international publishers. He has taught undergraduate courses in Period I and Period V at Muğla Sıtkı Koçman University Faculty of Medicine, master’s courses within the ENT Department Specialist training, and Radiation Therapy associate degree courses at Istinye University Health Services Vocational School. He is currently involved in 2 ongoing TÜBİTAK Projects. He is married and has one son.